PharmChem Laboratories Inc (PCHM)

[LMLYP]

When I posted, see link below or previous post, I used product sales as total sales, when in fact, product sales are accompanied by revenues from screenings. I have always assumed that screens is a small source of revenues, and would ask the company, if they are reading, what the breakdown looks like in their upcoming report. I believe it would benefit shareholders Joe, if your annual letter was treated a little bit more like a 10K filing.

The newer shareholders now, with your higher market cap, do real work, and we should all be treated the same. I believe I am entitled to know your process better without having to go through your oldest filings to see the birth of the patch, and find a more and more lines from each letter which you are doing, but to piece it all together I wanted more detail on what happened almost a couple of years ago by now by not going the pain management route with the main focus on the different assay methodologies and investments.

Additionally, I will stand by throwing out a number, this is my thinking only. If I say 40 cents in earnings, fully taxed, fully diluted, take it with a grain of salt, along with 25 cents in dividends.

With that said, 60-70% or more is not an atypical payout ratio.



https://investorshub.advfn.com/boards/read_msg.aspx?message_id=162191510